MedPath

A prospective randomised Rontgen Stereophotogrammatic Analysis (RSA) study using the uncemented Trident Tritanium acetabular component and the uncemented HA coated Symax hip stem in a single centre. Assessment of implant migration, bone remodeling and clinical function.

Completed
Conditions
hip osteoarthritis
hip prosthesis
10023213
10005944
Registration Number
NL-OMON44926
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
57
Inclusion Criteria

Patients aged between 35 and 70 years
Patients requiring uncemented primary THA
Patients with a diagnosis of osteoarthritis, rheumatoid arthritis, avascular necrosis or post-traumatic arthritis

Exclusion Criteria

Patients who require a revision of previous implanted THA
Patients with BMI>35
Patients who have had a prior procedure of femoral osteotomy patients with active or suspected infection patients with malignancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary objective is to determine the prosthetic migration of the<br /><br>uncemented Trident acetabular component (Tritanium or HA coated (controls))<br /><br>and the uncemented HA coated Symax stem from post-op until 2 years after<br /><br>implantation using the model based RSA technique. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath